Citation:Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al 2006

Citation

Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006 Apr 19;98(8):529-34 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16622122.

This is a publication of PCPT

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al 2006	For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?	Suzanne Hughes	completed
Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, et al 2006 2	For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?	Tracy Tsang	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?|]] (compare critical appraisals)
• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what PSA testing strategies with or without DRE perform best in detecting any prostate cancer or high grade prostate cancer diagnosed in biopsy tissue?|]] (compare critical appraisals)